{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:14:44Z","timestamp":1791245684322,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/nrmicro2015","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T06:13:37Z","timestamp":1226643217000},"page":"913-924","source":"Crossref","is-referenced-by-count":243,"title":["The curious case of the tumour virus: 50 years of Burkitt's lymphoma"],"prefix":"10.1038","volume":"6","author":[{"given":"David A.","family":"Thorley-Lawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Allday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrmicro2015_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt, D. A sarcoma involving the jaws in African children. Br. J. Surg. 46, 218\u2013223 (1958).","journal-title":"Br. J. Surg."},{"key":"BFnrmicro2015_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bmj.1.5378.259","volume":"1","author":"JN Davies","year":"1964","unstructured":"Davies, J. N. et al. Cancer in an African community, 1897\u20131956. An analysis of the records of Mengo Hospital, Kampala, Uganda. I. Br. Med. J. 1, 259\u2013264 (1964).","journal-title":"Br. Med. J."},{"key":"BFnrmicro2015_CR3","first-page":"113","volume-title":"Epstein\u2013Barr Virus","author":"BE Griffin","year":"2005","unstructured":"Griffin, B. E. & Rochford, R. in Epstein\u2013Barr Virus (ed. Robertson, E. S.) 113\u2013138 (Caister Academic, Norfolk, 2005)."},{"key":"BFnrmicro2015_CR4","first-page":"2424","volume":"27","author":"DH Wright","year":"1967","unstructured":"Wright, D. H. The epidemiology of Burkitt's tumor. Cancer Res. 27, 2424\u20132438 (1967).","journal-title":"Cancer Res."},{"key":"BFnrmicro2015_CR5","first-page":"337","volume":"6","author":"DH Wright","year":"1971","unstructured":"Wright, D. H. Burkitt's lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol. Annu. 6, 337\u2013363 (1971).","journal-title":"Pathol. Annu."},{"key":"BFnrmicro2015_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"BFnrmicro2015_CR7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/JB.91.3.1248-1256.1966","volume":"91","author":"G Henle","year":"1966","unstructured":"Henle, G. & Henle, W. Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol. 91, 1248\u20131256 (1966).","journal-title":"J. Bacteriol."},{"key":"BFnrmicro2015_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/237033a0","volume":"237","author":"G Manolov","year":"1972","unstructured":"Manolov, G. & Manolova, Y. Marker band in one chromosome 14 from Burkitt lymphomas. Nature 237, 33\u201334 (1972).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0092-8674(83)90449-X","volume":"32","author":"G Klein","year":"1983","unstructured":"Klein, G. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell 32, 311\u2013315 (1983).","journal-title":"Cell"},{"key":"BFnrmicro2015_CR10","first-page":"341","volume-title":"Burkitt's Lymphoma: a Human Cancer Model","author":"P Leder","year":"1985","unstructured":"Leder, P. in Burkitt's Lymphoma: a Human Cancer Model (eds Lenoir, G. M., O'Conor, G. T. & Olweny, C. L. M.) 341\u2013371 (Oxford Univ. Press, New York, 1985)."},{"key":"BFnrmicro2015_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","volume":"55","author":"I Magrath","year":"1990","unstructured":"Magrath, I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55, 133\u2013270 (1990).","journal-title":"Adv. Cancer Res."},{"key":"BFnrmicro2015_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G de-The","year":"1978","unstructured":"de-The, G. et al. Epidemiological evidence for causal relationship between Epstein\u2013Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274, 756\u2013761 (1978).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0022-2836(76)90331-4","volume":"102","author":"T Lindahl","year":"1976","unstructured":"Lindahl, T. et al. Covalently closed circular duplex DNA of Epstein\u2013Barr virus in a human lymphoid cell line. J. Mol. Biol. 102, 511\u2013530 (1976).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro2015_CR14","first-page":"599","volume":"1","author":"BM Reedman","year":"1973","unstructured":"Reedman, B. M. & Klein, G. Cellular localisation of an Epstein\u2013Barr virus (EBV) associated complement fixing antigen in producer and non-producer cell lines. Int. J. Cancer 1, 599\u2013620 (1973).","journal-title":"Int. J. Cancer"},{"key":"BFnrmicro2015_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.humpath.2007.10.030","volume":"39","author":"AT Deyrup","year":"2008","unstructured":"Deyrup, A. T. Epstein\u2013Barr virus-associated epithelial and mesenchymal neoplasms. Hum. Pathol. 39, 473\u2013483 (2008).","journal-title":"Hum. Pathol."},{"key":"BFnrmicro2015_CR16","first-page":"2655","volume-title":"Virology","author":"AB Rickinson","year":"2007","unstructured":"Rickinson, A. B. & Kieff, E. D. in Virology Vol. 2 (eds Knipe, D. M. & Howley, P. M.) 2655\u20132700 (Lippincott Williams and Wilkins, New York, 2007)."},{"key":"BFnrmicro2015_CR17","first-page":"113","volume-title":"Epstein\u2013Barr Virus","author":"DA Thorley-Lawson","year":"2005","unstructured":"Thorley-Lawson, D. A. in Epstein\u2013Barr Virus (ed. Robertson, E. S.) 113\u2013138 (Caister Academic, Norfolk, 2005)."},{"key":"BFnrmicro2015_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","volume":"157","author":"W Henle","year":"1967","unstructured":"Henle, W., Diehl, V., Kohn, G., Zur Hausen, H. & Henle, G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157, 1064\u20131065 (1967).","journal-title":"Science"},{"key":"BFnrmicro2015_CR19","first-page":"2603","volume-title":"Virology","author":"ED Kieff","year":"2007","unstructured":"Kieff, E. D. in Virology Vol. 2 (eds Knipe, D. M. & Howley, P. M.) 2603\u20132655 (Lippincott Williams and Wilkins, New York, 2007)."},{"key":"BFnrmicro2015_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1084\/jem.162.1.45","volume":"162","author":"DA Thorley-Lawson","year":"1985","unstructured":"Thorley-Lawson, D. A. & Mann, K. P. Early events in Epstein\u2013Barr virus infection provide a model for B cell activation. J. Exp. Med. 162, 45\u201359 (1985).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson, D. A. Epstein\u2013Barr virus: exploiting the immune system. Nature Rev. Immunol. 1, 75\u201382 (2001).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro2015_CR22","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson, D. A. & Gross, A. Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328\u20131337 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2015_CR23","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang, D., Liebowitz, D. & Kieff, E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831\u2013840 (1985).","journal-title":"Cell"},{"key":"BFnrmicro2015_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1084\/jem.153.2.235","volume":"153","author":"JE Robinson","year":"1981","unstructured":"Robinson, J. E., Smith, D. & Niederman, J. Plasmacytic differentiation of circulating Epstein\u2013Barr virus-infected B lymphocytes during acute infectious mononucleosis. J. Exp. Med. 153, 235\u2013244 (1981).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR25","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/JVI.71.7.4882-4891.1997","volume":"71","author":"EM Miyashita","year":"1997","unstructured":"Miyashita, E. M., Yang, B., Babcock, G. J. & Thorley-Lawson, D. A. Identification of the site of Epstein\u2013Barr virus persistence in vivo as a resting B cell. J. Virol. 71, 4882\u20134891 (1997).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0092-8674(95)90513-8","volume":"80","author":"EM Miyashita","year":"1995","unstructured":"Miyashita, E. M., Yang, B., Lam, K. M., Crawford, D. H. & Thorley-Lawson, D. A. A novel form of Epstein\u2013Barr virus latency in normal B cells in vivo. Cell 80, 593\u2013601 (1995).","journal-title":"Cell"},{"key":"BFnrmicro2015_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-065X.1999.tb01328.x","volume":"170","author":"R Khanna","year":"1999","unstructured":"Khanna, R., Moss, D. J. & Burrows, S. R. Vaccine strategies against Epstein\u2013Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation. Immunol. Rev. 170, 49\u201364 (1999).","journal-title":"Immunol. Rev."},{"key":"BFnrmicro2015_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/jcp.53.4.248","volume":"53","author":"P Hopwood","year":"2000","unstructured":"Hopwood, P. & Crawford, D. H. The role of EBV in post-transplant malignancies: a review. J. Clin. Pathol. 53, 248\u2013254 (2000).","journal-title":"J. Clin. Pathol."},{"key":"BFnrmicro2015_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.190.4.567","volume":"190","author":"GJ Babcock","year":"1999","unstructured":"Babcock, G. J., Decker, L. L., Freeman, R. B. & Thorley-Lawson, D. A. Epstein\u2013Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190, 567\u2013576 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR30","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht, J. L. & Aster, J. C. Molecular biology of Burkitt's lymphoma. J. Clin. Oncol. 18, 3707\u20133721 (2000).","journal-title":"J. Clin. Oncol."},{"key":"BFnrmicro2015_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ijc.2910150217","volume":"15","author":"K Nilsson","year":"1975","unstructured":"Nilsson, K. & Ponten, J. Classification and biological nature of established human hematopoietic cell lines. Int. J. Cancer 15, 321\u2013341 (1975).","journal-title":"Int. J. Cancer"},{"key":"BFnrmicro2015_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","volume":"139","author":"CD Gregory","year":"1987","unstructured":"Gregory, C. D. et al. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J. Immunol. 139, 313\u2013318 (1987).","journal-title":"J. Immunol."},{"key":"BFnrmicro2015_CR33","doi-asserted-by":"publisher","first-page":"10565","DOI":"10.1073\/pnas.92.23.10565","volume":"92","author":"BC Schaefer","year":"1995","unstructured":"Schaefer, B. C., Strominger, J. L. & Speck, S. H. Redefining the Epstein\u2013Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl Acad. Sci. USA 92, 10565\u201310569 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR34","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.66.5.2689-2697.1992","volume":"66","author":"L Brooks","year":"1992","unstructured":"Brooks, L., Yao, Q. Y., Rickinson, A. B. & Young, L. S. Epstein\u2013Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66, 2689\u20132697 (1992).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.177.2.339","volume":"177","author":"EM Deacon","year":"1993","unstructured":"Deacon, E. M. et al. Epstein\u2013Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177, 339\u2013349 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-3-642-67236-1_4","volume-title":"The Epstein\u2013Barr Virus","author":"W Henle","year":"1979","unstructured":"Henle, W. & Henle, G. in The Epstein\u2013Barr Virus (eds Epstein, M. A. & Achong, B. G.) 61\u201378 (Springer-Verlag, Berlin, 1979)."},{"key":"BFnrmicro2015_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock, G. J., Decker, L. L., Volk, M. & Thorley-Lawson, D. A. EBV persistence in memory B cells in vivo. Immunity 9, 395\u2013404 (1998).","journal-title":"Immunity"},{"key":"BFnrmicro2015_CR38","doi-asserted-by":"publisher","first-page":"18093","DOI":"10.1073\/pnas.0509311102","volume":"102","author":"TA Souza","year":"2005","unstructured":"Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K. & Thorley-Lawson, D. A. Peripheral B cells latently infected with Epstein\u2013Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl Acad. Sci. USA 102, 18093\u201318098 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR39","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4049\/jimmunol.179.5.3153","volume":"179","author":"TA Souza","year":"2007","unstructured":"Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K. & Thorley-Lawson, D. A. Influence of EBV on the peripheral blood memory B cell compartment. J. Immunol. 179, 3153\u20133160 (2007).","journal-title":"J. Immunol."},{"key":"BFnrmicro2015_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1073\/pnas.2237267100","volume":"101","author":"D Hochberg","year":"2004","unstructured":"Hochberg, D. et al. Demonstration of the Burkitt's lymphoma Epstein\u2013Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl Acad. Sci. USA 101, 239\u2013244 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553\u2013563 (2000).","journal-title":"Cell"},{"key":"BFnrmicro2015_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ng.2007.35","volume":"40","author":"L Pasqualucci","year":"2008","unstructured":"Pasqualucci, L. et al. AID is required for germinal center-derived lymphomagenesis. Nature Genet. 40, 108\u2013112 (2008).","journal-title":"Nature Genet."},{"key":"BFnrmicro2015_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein, U. & Dalla-Favera, R. Germinal centres: role in B-cell physiology and malignancy. Nature Rev. Immunol. 8, 22\u201333 (2008).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro2015_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1084\/jem.20070884","volume":"204","author":"Y Dorsett","year":"2007","unstructured":"Dorsett, Y. et al. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204, 2225\u20132232 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng0993-56","volume":"5","author":"K Bhatia","year":"1993","unstructured":"Bhatia, K. et al. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nature Genet. 5, 56\u201361 (1993).","journal-title":"Nature Genet."},{"key":"BFnrmicro2015_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533\u2013538 (1985).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR47","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","volume":"192","author":"AL Kovalchuk","year":"2000","unstructured":"Kovalchuk, A. L. et al. Burkitt lymphoma in the mouse. J. Exp. Med. 192, 1183\u20131190 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","volume":"16","author":"CV Dang","year":"2006","unstructured":"Dang, C. V. et al. The c-Myc target gene network. Semin. Cancer Biol. 16, 253\u2013264 (2006).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrmicro2015_CR49","doi-asserted-by":"publisher","first-page":"17834","DOI":"10.1073\/pnas.0604129103","volume":"103","author":"KI Zeller","year":"2006","unstructured":"Zeller, K. I. et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl Acad. Sci. USA 103, 17834\u201317839 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang, T. C. et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet. 40, 43\u201350 (2008).","journal-title":"Nature Genet."},{"key":"BFnrmicro2015_CR51","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O'Donnell","year":"2005","unstructured":"O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. & Mendell, J. T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839\u2013843 (2005).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR52","first-page":"169","volume":"302","author":"M Wade","year":"2006","unstructured":"Wade, M. & Wahl, G. M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr. Top. Microbiol. Immunol. 302, 169\u2013203 (2006).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnrmicro2015_CR53","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/ijc.22372","volume":"120","author":"M Schlee","year":"2007","unstructured":"Schlee, M. et al. c-MYC activation impairs the NF-\u03baB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. Int. J. Cancer 120, 1387\u20131395 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnrmicro2015_CR54","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1073\/pnas.072495599","volume":"99","author":"MS Staege","year":"2002","unstructured":"Staege, M. S. et al. MYC overexpression imposes a nonimmunogenic phenotype on Epstein\u2013Barr virus-infected B cells. Proc. Natl Acad. Sci. USA 99, 4550\u20134555 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR55","doi-asserted-by":"publisher","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G Kennedy","year":"2003","unstructured":"Kennedy, G., Komano, J. & Sugden, B. Epstein\u2013Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl Acad. Sci. USA 100, 14269\u201314274 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR56","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J Komano","year":"1999","unstructured":"Komano, J., Maruo, S., Kurozumi, K., Oda, T. & Takada, K. Oncogenic role of Epstein\u2013Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J. Virol. 73, 9827\u20139831 (1999).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR57","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/MCB.19.3.1651","volume":"19","author":"IK Ruf","year":"1999","unstructured":"Ruf, I. K. et al. Epstein\u2013Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol. Cell. Biol. 19, 1651\u20131660 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrmicro2015_CR58","doi-asserted-by":"publisher","first-page":"14935","DOI":"10.1073\/pnas.0509988103","volume":"103","author":"GL Kelly","year":"2006","unstructured":"Kelly, G. L., Milner, A. E., Baldwin, G. S., Bell, A. I. & Rickinson, A. B. Three restricted forms of Epstein\u2013Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA 103, 14935\u201314940 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR59","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1084\/jem.168.6.2059","volume":"168","author":"EA Hurley","year":"1988","unstructured":"Hurley, E. A. & Thorley-Lawson, D. A. B cell activation and the establishment of Epstein\u2013Barr virus latency. J. Exp. Med. 168, 2059\u20132075 (1988).","journal-title":"J. Exp. Med."},{"key":"BFnrmicro2015_CR60","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","volume":"87","author":"M Woisetschlaeger","year":"1990","unstructured":"Woisetschlaeger, M., Yandava, C. N., Furmanski, L. A., Strominger, J. L. & Speck, S. H. Promoter switching in Epstein\u2013Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl Acad. Sci. USA 87, 1725\u20131729 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405\u2013411 (1998).","journal-title":"Immunity"},{"key":"BFnrmicro2015_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ni1036","volume":"5","author":"S Casola","year":"2004","unstructured":"Casola, S. et al. B cell receptor signal strength determines B cell fate. Nature Immunol. 5, 317\u2013327 (2004).","journal-title":"Nature Immunol."},{"key":"BFnrmicro2015_CR63","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","volume":"16","author":"O Gires","year":"1997","unstructured":"Gires, O. et al. Latent membrane protein 1 of Epstein\u2013Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131\u20136140 (1997).","journal-title":"EMBO J."},{"key":"BFnrmicro2015_CR64","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","volume":"171","author":"B He","year":"2003","unstructured":"He, B., Raab-Traub, N., Casali, P. & Cerutti, A. EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171, 5215\u20135224 (2003).","journal-title":"J. Immunol."},{"key":"BFnrmicro2015_CR65","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1128\/JVI.78.23.13253-13261.2004","volume":"78","author":"D Panagopoulos","year":"2004","unstructured":"Panagopoulos, D., Victoratos, P., Alexiou, M., Kollias, G. & Mosialos, G. Comparative analysis of signal transduction by CD40 and the Epstein\u2013Barr virus oncoprotein LMP1 in vivo. J. Virol. 78, 13253\u201313261 (2004).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR66","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1128\/JVI.68.9.5375-5383.1994","volume":"68","author":"PD Ling","year":"1994","unstructured":"Ling, P. D., Hsieh, J. J., Ruf, I. K., Rawlins, D. R. & Hayward, S. D. EBNA-2 upregulation of Epstein\u2013Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68, 5375\u20135383 (1994).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.7716513","volume":"268","author":"S Artavanis-Tsakonas","year":"1995","unstructured":"Artavanis-Tsakonas, S., Matsuno, K. & Fortini, M. E. Notch signaling. Science 268, 225\u2013232 (1995).","journal-title":"Science"},{"key":"BFnrmicro2015_CR68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ni1453","volume":"8","author":"K Tanigaki","year":"2007","unstructured":"Tanigaki, K. & Honjo, T. Regulation of lymphocyte development by Notch signaling. Nature Immunol. 8, 451\u2013456 (2007).","journal-title":"Nature Immunol."},{"key":"BFnrmicro2015_CR69","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1101\/gad.987402","volume":"16","author":"S Barolo","year":"2002","unstructured":"Barolo, S., Stone, T., Bang, A. G. & Posakony, J. W. Default repression and Notch signaling: Hairless acts as an adaptor to recruit the corepressors Groucho and dCtBP to Suppressor of Hairless. Genes Dev. 16, 1964\u20131976 (2002).","journal-title":"Genes Dev."},{"key":"BFnrmicro2015_CR70","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.biocel.2007.01.025","volume":"39","author":"G Chinnadurai","year":"2007","unstructured":"Chinnadurai, G. Transcriptional regulation by C-terminal binding proteins. Int. J. Biochem. Cell Biol. 39, 1593\u20131607 (2007).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnrmicro2015_CR71","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1002\/j.1460-2075.1994.tb06824.x","volume":"13","author":"U Zimber-Strobl","year":"1994","unstructured":"Zimber-Strobl, U. et al. Epstein\u2013Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J\u03ba, the homologue of Drosophila Suppressor of Hairless. EMBO J. 13, 4973\u20134982 (1994).","journal-title":"EMBO J."},{"key":"BFnrmicro2015_CR72","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1128\/JVI.71.11.8552-8562.1997","volume":"71","author":"SA Radkov","year":"1997","unstructured":"Radkov, S. A. et al. Epstein\u2013Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J. Virol. 71, 8552\u20138562 (1997).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR73","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1006\/viro.1994.1687","volume":"205","author":"A Le Roux","year":"1994","unstructured":"Le Roux, A., Kerdiles, B., Walls, D., Dedieu, J. F. & Perricaudet, M. The Epstein\u2013Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205, 596\u2013602 (1994).","journal-title":"Virology"},{"key":"BFnrmicro2015_CR74","doi-asserted-by":"publisher","first-page":"47197","DOI":"10.1074\/jbc.M208116200","volume":"277","author":"M Hickabottom","year":"2002","unstructured":"Hickabottom, M., Parker, G. A., Freemont, P., Crook, T. & Allday, M. J. Two nonconsensus sites in the Epstein\u2013Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J. Biol. Chem. 277, 47197\u201347204 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro2015_CR75","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1128\/JVI.75.16.7749-7755.2001","volume":"75","author":"R Touitou","year":"2001","unstructured":"Touitou, R., Hickabottom, M., Parker, G., Crook, T. & Allday, M. J. Physical and functional interactions between the corepressor CtBP and the Epstein\u2013Barr virus nuclear antigen EBNA3C. J. Virol. 75, 7749\u20137755 (2001).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR76","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/JVI.73.7.5688-5697.1999","volume":"73","author":"SA Radkov","year":"1999","unstructured":"Radkov, S. A. et al. Epstein\u2013Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73, 5688\u20135697 (1999).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR77","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genet. 33, 245\u2013254 (2003).","journal-title":"Nature Genet."},{"key":"BFnrmicro2015_CR78","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1128\/JVI.02172-06","volume":"81","author":"L Day","year":"2007","unstructured":"Day, L. et al. Chromatin profiling of Epstein\u2013Barr virus latency control region. J. Virol. 81, 6389\u20136401 (2007).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1521-6616(03)00198-0","volume":"109","author":"Q Tao","year":"2003","unstructured":"Tao, Q. & Robertson, K. D. Stealth technology: how Epstein\u2013Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin. Immunol. 109, 53\u201363 (2003).","journal-title":"Clin. Immunol."},{"key":"BFnrmicro2015_CR80","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1128\/JVI.73.12.9959-9968.1999","volume":"73","author":"EJ Paulson","year":"1999","unstructured":"Paulson, E. J. & Speck, S. H. Differential methylation of Epstein\u2013Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J. Virol. 73, 9959\u20139968 (1999).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ni1036","volume":"5","author":"S Casola","year":"2004","unstructured":"Casola, S. et al. B cell receptor signal strength determines B cell fate. Nature Immunol. 5, 317\u2013327 (2004).","journal-title":"Nature Immunol."},{"key":"BFnrmicro2015_CR82","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1128\/JVI.00433-06","volume":"80","author":"M Swanson-Mungerson","year":"2006","unstructured":"Swanson-Mungerson, M., Bultema, R. & Longnecker, R. Epstein\u2013Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J. Virol. 80, 6764\u20136770 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.it.2007.03.002","volume":"28","author":"M Swanson-Mungerson","year":"2007","unstructured":"Swanson-Mungerson, M. & Longnecker, R. Epstein\u2013Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol. 28, 213\u2013218 (2007).","journal-title":"Trends Immunol."},{"key":"BFnrmicro2015_CR84","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1128\/JVI.79.12.7355-7362.2005","volume":"79","author":"MA Swanson-Mungerson","year":"2005","unstructured":"Swanson-Mungerson, M. A., Caldwell, R. G., Bultema, R. & Longnecker, R. Epstein\u2013Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J. Virol. 79, 7355\u20137362 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR85","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.1073\/pnas.95.20.11963","volume":"95","author":"W Kulwichit","year":"1998","unstructured":"Kulwichit, W. et al. Expression of the Epstein\u2013Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl Acad. Sci. USA 95, 11963\u201311968 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR86","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ijc.20654","volume":"113","author":"LL Kis","year":"2005","unstructured":"Kis, L. L. et al. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2. Int. J. Cancer 113, 937\u2013945 (2005).","journal-title":"Int. J. Cancer"},{"key":"BFnrmicro2015_CR87","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1182\/blood-2005-06-2569","volume":"107","author":"LL Kis","year":"2006","unstructured":"Kis, L. L., Takahara, M., Nagy, N., Klein, G. & Klein, E. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Blood 107, 2928\u20132935 (2006).","journal-title":"Blood"},{"key":"BFnrmicro2015_CR88","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.virol.2007.12.027","volume":"374","author":"D Konforte","year":"2008","unstructured":"Konforte, D., Simard, N. & Paige, C. J. Interleukin-21 regulates expression of key Epstein\u2013Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells. Virology 374, 100\u2013113 (2008).","journal-title":"Virology"},{"key":"BFnrmicro2015_CR89","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/j.1460-2075.1995.tb07124.x","volume":"14","author":"MJ Allday","year":"1995","unstructured":"Allday, M. J., Sinclair, A., Parker, G., Crawford, D. H. & Farrell, P. J. Epstein\u2013Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14, 1382\u20131391 (1995).","journal-title":"EMBO J."},{"key":"BFnrmicro2015_CR90","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1128\/JVI.01363-06","volume":"80","author":"J O'Nions","year":"2006","unstructured":"O'Nions, J., Turner, A., Craig, R. & Allday, M. J. Epstein\u2013Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53. J. Virol. 80, 12408\u201312413 (2006).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR91","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.onc.1210668","volume":"27","author":"E Anderton","year":"2008","unstructured":"Anderton, E. et al. Two Epstein\u2013Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27, 421\u2013433 (2008).","journal-title":"Oncogene"},{"key":"BFnrmicro2015_CR92","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","volume":"73","author":"C Kaiser","year":"1999","unstructured":"Kaiser, C. et al. The proto-oncogene c-myc is a direct target gene of Epstein\u2013Barr virus nuclear antigen 2. J. Virol. 73, 4481\u20134484 (1999).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR93","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrmicro1089","volume":"3","author":"R Rochford","year":"2005","unstructured":"Rochford, R., Cannon, M. J. & Moormann, A. M. Endemic Burkitt's lymphoma: a polymicrobial disease? Nature Rev. Microbiol. 3, 182\u2013187 (2005).","journal-title":"Nature Rev. Microbiol."},{"key":"BFnrmicro2015_CR94","first-page":"177","volume-title":"Burkitt's Lymphoma: a Human Cancer Model","author":"RH Morrow","year":"1985","unstructured":"Morrow, R. H. in Burkitt's Lymphoma: a Human Cancer Model (eds Lenoir, G. M., O'Conor, G. T. & Olweny, C. L. M.) 177\u2013185 (Oxford Univ. Press, New York, 1985)."},{"key":"BFnrmicro2015_CR95","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/oxfordjournals.aje.a115189","volume":"129","author":"A Geser","year":"1989","unstructured":"Geser, A., Brubaker, G. & Draper, C. C. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am. J. Epidemiol. 129, 740\u2013752 (1989).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrmicro2015_CR96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1172\/JCI33700","volume":"118","author":"KH Maclean","year":"2008","unstructured":"Maclean, K. H., Dorsey, F. C., Cleveland, J. L. & Kastan, M. B. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J. Clin. Invest. 118, 79\u201388 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrmicro2015_CR97","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1086\/428910","volume":"191","author":"AM Moormann","year":"2005","unstructured":"Moormann, A. M. et al. Exposure to holoendemic malaria results in elevated Epstein\u2013Barr virus loads in children. J. Infect. Dis. 191, 1233\u20131238 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2015_CR98","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ijc.2910310609","volume":"31","author":"DJ Moss","year":"1983","unstructured":"Moss, D. J. et al. A comparison of Epstein\u2013Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int. J. Cancer 31, 727\u2013732 (1983).","journal-title":"Int. J. Cancer"},{"key":"BFnrmicro2015_CR99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2249.1990.tb05236.x","volume":"80","author":"HC Whittle","year":"1990","unstructured":"Whittle, H. C. et al. The effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin. Exp. Immunol. 80, 213\u2013218 (1990).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrmicro2015_CR100","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.141.8.2755","volume":"141","author":"M Ho","year":"1988","unstructured":"Ho, M. et al. Defective production of and response to IL-2 in acute human falciparum malaria. J. Immunol. 141, 2755\u20132759 (1988).","journal-title":"J. Immunol."},{"key":"BFnrmicro2015_CR101","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/infdis\/153.4.763","volume":"153","author":"M Ho","year":"1986","unstructured":"Ho, M. et al. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J. Infect. Dis. 153, 763\u2013771 (1986).","journal-title":"J. Infect. Dis."},{"key":"BFnrmicro2015_CR102","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1128\/IAI.72.9.5412-5418.2004","volume":"72","author":"D Donati","year":"2004","unstructured":"Donati, D. et al. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect. Immun. 72, 5412\u20135418 (2004).","journal-title":"Infect. Immun."},{"key":"BFnrmicro2015_CR103","first-page":"173","volume":"7","author":"GM Lenoir","year":"1987","unstructured":"Lenoir, G. M. & Bornkamm, G. W. Burkitt's lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario. Adv. Viral Oncol. 7, 173\u2013206 (1987).","journal-title":"Adv. Viral Oncol."},{"key":"BFnrmicro2015_CR104","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jnci\/djm010","volume":"99","author":"RJ Biggar","year":"2007","unstructured":"Biggar, R. J., Chaturvedi, A. K., Goedert, J. J. & Engels, E. A. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J. Natl Cancer Inst. 99, 962\u2013972 (2007).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrmicro2015_CR105","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4269\/ajtmh.1999.60.641","volume":"60","author":"PB Bloland","year":"1999","unstructured":"Bloland, P. B. et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am. J. Trop. Med. Hyg. 60, 641\u2013648 (1999).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnrmicro2015_CR106","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.4049\/jimmunol.175.5.2968","volume":"175","author":"C Clybouw","year":"2005","unstructured":"Clybouw, C. et al. EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis. J. Immunol. 175, 2968\u20132973 (2005).","journal-title":"J. Immunol."},{"key":"BFnrmicro2015_CR107","doi-asserted-by":"publisher","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","volume":"79","author":"GL Kelly","year":"2005","unstructured":"Kelly, G. L. et al. Epstein\u2013Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79, 10709\u201310717 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR108","first-page":"501","volume-title":"Epstein\u2013Barr Virus","author":"JS Knight","year":"2005","unstructured":"Knight, J. S. & Robertson, E. S. in Epstein\u2013Barr Virus (ed. Robertson, E. S.) 501\u2013532 (Caister Academic, Norfolk, 2005)."},{"key":"BFnrmicro2015_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0065-230X(04)92006-4","volume":"92","author":"J O'Nions","year":"2004","unstructured":"O'Nions, J. & Allday, M. J. Deregulation of the cell cycle by the Epstein\u2013Barr virus. Adv. Cancer Res. 92, 119\u2013186 (2004).","journal-title":"Adv. Cancer Res."},{"key":"BFnrmicro2015_CR110","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1038\/sj.onc.1210324","volume":"26","author":"SA Kamranvar","year":"2007","unstructured":"Kamranvar, S. A., Gruhne, B., Szeles, A. & Masucci, M. G. Epstein\u2013Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene 26, 5115\u20135123 (2007).","journal-title":"Oncogene"},{"key":"BFnrmicro2015_CR111","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0035-9203(00)90240-2","volume":"94","author":"C van den Bosch","year":"2000","unstructured":"van den Bosch, C. & Lloyd, G. Chikungunya fever as a risk factor for endemic Burkitt's lymphoma in Malawi. Trans. R. Soc. Trop. Med. Hyg. 94, 704\u2013705 (2000).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnrmicro2015_CR112","first-page":"933","volume":"14","author":"S Imai","year":"1994","unstructured":"Imai, S. et al. African Burkitt's lymphoma: a plant, Euphorbia tirucalli, reduces Epstein\u2013Barr virus-specific cellular immunity. Anticancer Res. 14, 933\u2013936 (1994).","journal-title":"Anticancer Res."},{"key":"BFnrmicro2015_CR113","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt, B. et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br. J. Haematol. 131, 39\u201349 (2005).","journal-title":"Br. J. Haematol."},{"key":"BFnrmicro2015_CR114","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"JT Sandlund","year":"1996","unstructured":"Sandlund, J. T., Downing, J. R. & Crist, W. M. Non-Hodgkin's lymphoma in childhood. N. Engl. J. Med. 334, 1238\u20131248 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2015_CR115","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","volume":"20","author":"R Kuppers","year":"2001","unstructured":"Kuppers, R. & Dalla-Favera, R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580\u20135594 (2001).","journal-title":"Oncogene"},{"key":"BFnrmicro2015_CR116","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nri953","volume":"2","author":"AL Shaffer","year":"2002","unstructured":"Shaffer, A. L., Rosenwald, A. & Staudt, L. M. Lymphoid malignancies: the dark side of B-cell differentiation. Nature Rev. Immunol. 2, 920\u2013932 (2002).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro2015_CR117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood.V86.1.28.bloodjournal86128","volume":"86","author":"T Onizuka","year":"1995","unstructured":"Onizuka, T. et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86, 28\u201337 (1995).","journal-title":"Blood"},{"key":"BFnrmicro2015_CR118","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave, S. S. et al. Molecular diagnosis of Burkitt's lymphoma. N. Engl. J. Med. 354, 2431\u20132442 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrmicro2015_CR119","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1073\/pnas.0437996100","volume":"100","author":"U Klein","year":"2003","unstructured":"Klein, U. et al. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl Acad. Sci. USA 100, 2639\u20132644 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro2015_CR120","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(01)00194-7","volume":"15","author":"AL Shaffer","year":"2001","unstructured":"Shaffer, A. L. et al. Signatures of the immune response. Immunity 15, 375\u2013385 (2001).","journal-title":"Immunity"},{"key":"BFnrmicro2015_CR121","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/324158a0","volume":"324","author":"FG Haluska","year":"1986","unstructured":"Haluska, F. G., Finver, S., Tsujimoto, Y. & Croce, C. M. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature 324, 158\u2013161 (1986).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR122","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","volume":"106","author":"C Bellan","year":"2005","unstructured":"Bellan, C. et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood 106, 1031\u20131036 (2005).","journal-title":"Blood"},{"key":"BFnrmicro2015_CR123","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/carcin\/13.10.1681","volume":"13","author":"M Potter","year":"1992","unstructured":"Potter, M. & Wiener, F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13, 1681\u20131697 (1992).","journal-title":"Carcinogenesis"},{"key":"BFnrmicro2015_CR124","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0959-437X(94)90100-7","volume":"4","author":"EA Harrington","year":"1994","unstructured":"Harrington, E. A., Fanidi, A. & Evan, G. I. Oncogenes and cell death. Curr. Opin. Genet. Dev. 4, 120\u2013129 (1994).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnrmicro2015_CR125","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","volume":"13","author":"CM Eischen","year":"1999","unstructured":"Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF\u2013Mdm2\u2013p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658\u20132669 (1999).","journal-title":"Genes Dev."},{"key":"BFnrmicro2015_CR126","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","volume":"12","author":"MS Lindstrom","year":"2002","unstructured":"Lindstrom, M. S. & Wiman, K. G. Role of genetic and epigenetic changes in Burkitt lymphoma. Semin. Cancer Biol. 12, 381\u2013387 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrmicro2015_CR127","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nri1568","volume":"5","author":"A Strasser","year":"2005","unstructured":"Strasser, A. The role of BH3-only proteins in the immune system. Nature Rev. Immunol. 5, 189\u2013200 (2005).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrmicro2015_CR128","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2003-07-2469","volume":"103","author":"A Egle","year":"2004","unstructured":"Egle, A., Harris, A. W., Bath, M. L., O'Reilly, L. & Cory, S. VavP\u2013Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103, 2276\u20132283 (2004).","journal-title":"Blood"},{"key":"BFnrmicro2015_CR129","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","volume":"109","author":"C Mestre-Escorihuela","year":"2007","unstructured":"Mestre-Escorihuela, C. et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109, 271\u2013280 (2007).","journal-title":"Blood"},{"key":"BFnrmicro2015_CR130","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa, H. et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24, 1348\u20131358 (2005).","journal-title":"Oncogene"},{"key":"BFnrmicro2015_CR131","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ccr.2005.08.005","volume":"8","author":"CV Dang","year":"2005","unstructured":"Dang, C. V., O'Donnell, K. A. & Juopperi, T. The great MYC escape in tumorigenesis. Cancer Cell 8, 177\u2013178 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrmicro2015_CR132","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature03845","volume":"436","author":"MT Hemann","year":"2005","unstructured":"Hemann, M. T. et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436, 807\u2013811 (2005).","journal-title":"Nature"},{"key":"BFnrmicro2015_CR133","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1128\/JVI.00154-07","volume":"81","author":"PM Bhende","year":"2007","unstructured":"Bhende, P. M., Dickerson, S. J., Sun, X., Feng, W. H. & Kenney, S. C. X-box-binding protein 1 activates lytic Epstein\u2013Barr virus gene expression in combination with protein kinase D. J. Virol. 81, 7363\u20137370 (2007).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR134","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk, L. L. & Thorley-Lawson, D. A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein\u2013Barr virus in vivo. J. Virol. 79, 1296\u20131307 (2005).","journal-title":"J. Virol."},{"key":"BFnrmicro2015_CR135","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1128\/JVI.01055-07","volume":"81","author":"CC Sun","year":"2007","unstructured":"Sun, C. C. & Thorley-Lawson, D. A. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein\u2013Barr virus BZLF1 promoter. J. Virol. 81, 13566\u201313577 (2007).","journal-title":"J. Virol."}],"updated-by":[{"DOI":"10.1038\/nrmicro2068","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T00:00:00Z","timestamp":1229299200000}}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2015","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro2015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T02:11:47Z","timestamp":1684635107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro2015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":135,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFnrmicro2015"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro2015","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}